Prostate cancer incidence has been robustly correlated with markers of access to care in multiple studies: regions with higher income and educational attainment have higher prostate cancer incidence, which is attributable to increased use of prostate-specific antigen testing (17–20). The gene discussed is KLK3; the disease is Familial prostate cancer.